Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Esophagitis × Other × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Obesity 11 Polycystic Ovary Syndrome 6 Sexual Dysfunction, Physiological 3 Mucositis 3 Rectal Neoplasms 2 Obesity, Morbid 2 Neoplasms 2 Insulin Resistance 2 Head and Neck Neoplasms 2 Chemotherapy-induced Peripheral Neuropathy 2 Breast Neoplasms 2 Vitamin D Deficiency 1 Urinary Incontinence 1 Stomach Neoplasms 1 Spondylitis, Ankylosing 1 Smoking 1 Radiation Induced Oral Mucositis 1 Pulmonary Disease, Chronic Obstructive 1 Overweight 1 Opioid-Induced Constipation 1 Nutrition Disorders 1 Noncommunicable Diseases 1 Lymphoma, Follicular 1 Intestinal Diseases 1 Infertility 1 Hypokinesia 1 Hypertension 1 Hyperglycemia 1 Fistula 1 Esophagitis 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06958445 2025-05-06

SAFE

Taipei City Hospital

Phase 2 Enrolling by invitation

Breast Neoplasms, Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡